What is the address of DELPHARM?

The registered office of DELPHARM is located at Rue de la Cloche(AMA) 1, 4540 Amay.

Is DELPHARM still active?

Yes. According to the CBE (29 October 2026) DELPHARM is active, legal situation “Normale toestand”, started on 12 February 2021.

Is DELPHARM registered on Peppol?

Yes, DELPHARM is registered on the Peppol network with ID 0208:0763567469.

What is the enterprise number of DELPHARM?

The enterprise number of DELPHARM is BE0763567469.

When was DELPHARM founded?

DELPHARM was founded on 12 February 2021.

Who are the directors of DELPHARM?

According to the 2025 annual accounts, the directors of DELPHARM are: Delphine DUMONT.

Is DELPHARM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 February 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DELPHARM make in 2025?

DELPHARM posted a profit after taxes of € 34,356 in financial year 2025.

What is the revenue of DELPHARM?

As a small company, DELPHARM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 80,957.

Does DELPHARM have a website?

Yes, DELPHARM has a website at pharmaciecloche.be.

DELPHARM (Private Limited) - Amay - BE0763567469

Q: What does DELPHARM do?

DELPHARM is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 12 February 2021, 1 establishment.

Dossier DELPHARM, printed on 29 October 2026 from databakkes.be/en/0763567469/delpharm. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 18 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DELPHARM from Amay, company number BE0763567469, closed financial year 2025 with a result of € 34,356 after tax. For that financial year DELPHARM recorded a gross margin of € 80,957 and equity of € 350,889. Compared with financial year 2024, the result moved from € 33,563 to € 34,356. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 350,889

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 34,356

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 19,381

▲ 96% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 330,889.

People and assets in 2025

Vehicles and equipment

€ 69,929

▼ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 724,700

▼ 10% vs 2024

€ 90,497 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 17,084

▲ € 15,314 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 13,174

▼ 49% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 162,788 Gross margin 2022: € 162,788 First fiscal year in the series	€ 89,250 Gross margin 2023: € 89,250 ▼ 45% vs 2022 (€ 162,788) Unfavourable step	€ 81,584 Gross margin 2024: € 81,584 ▼ 9% vs 2023 (€ 89,250) Unfavourable step	€ 80,957 Gross margin 2025: € 80,957 ▼ 1% vs 2024 (€ 81,584) Unfavourable step	▼ 1%
Profit after taxes	€ 110,739 Profit after taxes 2022: € 110,739 First fiscal year in the series	€ 153,031 Profit after taxes 2023: € 153,031 ▲ 38% vs 2022 (€ 110,739) Favourable step	€ 33,563 Profit after taxes 2024: € 33,563 ▼ 78% vs 2023 (€ 153,031) Unfavourable step	€ 34,356 Profit after taxes 2025: € 34,356 ▲ 2% vs 2024 (€ 33,563) Favourable step	▲ 2%
Equity	€ 129,939 Equity 2022: € 129,939 First fiscal year in the series	€ 282,970 Equity 2023: € 282,970 ▲ 118% vs 2022 (€ 129,939) Favourable step	€ 316,533 Equity 2024: € 316,533 ▲ 12% vs 2023 (€ 282,970) Favourable step	€ 350,889 Equity 2025: € 350,889 ▲ 11% vs 2024 (€ 316,533) Favourable step	▲ 11%
Total debts	€ 1,084,750 Total debts 2022: € 1,084,750 First fiscal year in the series	€ 1,032,983 Total debts 2023: € 1,032,983 ▼ 5% vs 2022 (€ 1,084,750) Favourable step	€ 964,809 Total debts 2024: € 964,809 ▼ 7% vs 2023 (€ 1,032,983) Favourable step	€ 937,884 Total debts 2025: € 937,884 ▼ 3% vs 2024 (€ 964,809) Favourable step	▼ 3%
Cash	€ 40,979 Cash 2022: € 40,979 First fiscal year in the series	€ 26,640 Cash 2023: € 26,640 ▼ 35% vs 2022 (€ 40,979) Unfavourable step	€ 9,893 Cash 2024: € 9,893 ▼ 63% vs 2023 (€ 26,640) Unfavourable step	€ 19,381 Cash 2025: € 19,381 ▲ 96% vs 2024 (€ 9,893) Favourable step	▲ 96%
Retained profit	€ 109,939 Retained profit 2022: € 109,939 First fiscal year in the series	€ 262,970 Retained profit 2023: € 262,970 ▲ 139% vs 2022 (€ 109,939) Favourable step	€ 296,533 Retained profit 2024: € 296,533 ▲ 13% vs 2023 (€ 262,970) Favourable step	€ 330,889 Retained profit 2025: € 330,889 ▲ 12% vs 2024 (€ 296,533) Favourable step	▲ 12%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 800) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 842,778 Bank debt 2022: € 842,778 First fiscal year in the series	€ 881,878 Bank debt 2023: € 881,878 ▲ 5% vs 2022 (€ 842,778) Unfavourable step	€ 803,215 Bank debt 2024: € 803,215 ▼ 9% vs 2023 (€ 881,878) Favourable step	€ 724,700 Bank debt 2025: € 724,700 ▼ 10% vs 2024 (€ 803,215) Favourable step	▼ 10%
Balance sheet total	€ 1,214,689 Balance sheet total 2022: € 1,214,689 First fiscal year in the series	€ 1,315,953 Balance sheet total 2023: € 1,315,953 ▲ 8% vs 2022 (€ 1,214,689) Unchanged	€ 1,281,342 Balance sheet total 2024: € 1,281,342 ▼ 3% vs 2023 (€ 1,315,953) Unchanged	€ 1,288,773 Balance sheet total 2025: € 1,288,773 ▲ 1% vs 2024 (€ 1,281,342) Unchanged	▲ 1%

Key figures of DELPHARM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DELPHARM?

What happened at DELPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 34,356 (▲ 2% vs 2024). Source: NBB ↗
Mar 1, 2021 New establishment in Amay. KBO
Feb 12, 2021 Start of the company according to the CBE. KBO

In short

From € 110,739 profit in 2022 to € 34,356 profit in 2025.

Paid € 61,976 in corporate taxes since 2022.

Best year ever: 2023, with € 153,031 profit.

Paid out € 800 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Delphine DUMONT

DELPHARM

Pharmacie de la Cloche 100%

Behind DELPHARM is Delphine DUMONT. It owns 100% of Pharmacie de la Cloche itself.

Directors

According to the 2025 annual accounts

Delphine DUMONT

Director

Also active at: Pharmacie de la Cloche

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Cloche(AMA) 1

4540 Amay

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Pharmacie de la Cloche same network

€ 240,237 gross margin · 2025

CLOCHE

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmaciecloche.be

Technologies

ApacheElementorFont AwesomeGoogle FontsGoogle MapsPHPPWASwiperWordPressYoast SEOjQueryjQuery UIlazysizes

Hosting & Email

Email provider

Self-hosted

Hosting

HETZNER-AS, DE

Website info

HTTPS Ja

Languages FR

Features

Webshop Blog Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0763.567.469

VAT number

BE 0763.567.469

Registered office

Rue de la Cloche(AMA) 1, 4540 Amay

Names & denominations

DELPHARM

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 February 2021

Peppol

Active · Active since 23 Dec 2025

Contact

pharmaciecloche.be

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

DELPHARM

Warning lights

Financials

What happened to DELPHARM?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions